Penetration of aztreonam into human cerebrospinal fluid in the presence of meningeal inflammation

Cerebrospinal fluid of aztreonam were measured in 11 patients with meningeal inflammation. Two to eight hours after a single 2 gin intravenous dose, CSF aztreonam levels ranged from 0·76 to 16·6 mg/l. The mean CSF concentration in four patients with viral meningitis was 1·28 mg/l, which was lower th...

Full description

Saved in:
Bibliographic Details
Main Author: Mokhbat, J. E. (author)
Other Authors: Greenman, R. L. (author), Arcey, S. M. (author), Dickinson, G. M. (author), Sabath, L. D. (author), Platt, T. B. (author), Friedhoff, L. T. (author)
Format: article
Published: 1985
Online Access:http://hdl.handle.net/10725/5239
https://doi.org/10.1093/jac/15.5.637
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
https://academic.oup.com/jac/article-abstract/15/5/637/742754/Penetration-of-aztreonam-into-human-cerebrospinal
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cerebrospinal fluid of aztreonam were measured in 11 patients with meningeal inflammation. Two to eight hours after a single 2 gin intravenous dose, CSF aztreonam levels ranged from 0·76 to 16·6 mg/l. The mean CSF concentration in four patients with viral meningitis was 1·28 mg/l, which was lower than the mean con centration of 7·2 mg/l in the five with bacterial, cryptococcal or carcinomatous meningitis. Two patients with infected subdural drains were also sampled serially and had CSF levels greater than 1 mg/l between 1 and 8 h post dose. Penetration of aztreonam into the CSF in the presence of meningeal inflammation appears adequate to warrant therapeutic trials in patients infected with susceptible organisms.